Golden logo
    Create a WorkspaceQuery ToolSaved QueriesData RequestsListsPipelinesExploreFollowed Topics
    Upgrade to ProPricingAPI AccessHelp & Support
Log in
Sign up
NEW: You can now make knowledge queries using our new natural language prompt. Try it out now!
⟶
Aisling Capital

Aisling Capital

A venture capital and private equity firm investing in healthcare and biotechnology companies.

OverviewStructured DataIssuesContributorsActivity
Contents

Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.

Investments

The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.

Timeline

Invested in

Open in Query Tool

Patents

Open in Query Tool

Funding Rounds Participated In

Open in Query Tool

Further Resources

Title
Author
Link
Type
Date

References

aislingcapital.com
Is a
Organization
Organization
Investor
Investor
Company
Company
Venture capital firm
Venture capital firm

Company attributes

Industry
Biopharmaceutical
Biopharmaceutical
Consumer
Consumer
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Location
New York City
New York City
New York
New York
Founder
‌
Dennis Purcell
Full Address
888 SEVENTH AVENUE 12TH FLOOR NEW YORK, NY 10106
Founded Date
2000
CFO
‌
Robert Wenzel

Other attributes

Company Operating Status
Active
Country
United States
United States
Golden logo
Company
HomePress & MediaBlogCareers
We're hiring
Products
OverviewKnowledge GraphQuery ToolData RequestsKnowledge StorageAPIPricingEnterpriseProtocol
Legal
Terms of ServiceEnterprise Terms of ServicePrivacy Policy
Help
Help centerAPI DocumentationContact Us
By using this site, you agree to our Terms of Service.